Published in Cancer Weekly, July 1st, 2008
"Median follow-up was 43 months for IMRT and 48 months for I-125. The IMRT prescription dose ranged from 74-78 Gy, and I-125 prescription was 145 Gy. Acute...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.